1. World Health Organisation [WHO]. The importance of pharmacovigilance. Geneva: World Health Organisation; 2002.
2. Strengthening Pharmaceutical Systems [SPS]. Supporting Pharmacovigilance in Developing Countries: The Systems Perspective. Submitted to the U.S. Agency for International Development by the SPS Program. Arlington, VA: Management Sciences for Health; 2009.
3. World Health Organisation [WHO] (2010). Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. [online]. Available at:
http://www.who.int/hiv/pub/2010progressreport/report/en/index.html
[Accessed 1 September 2016].
4. Global Fund [GF]. (2011). The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). Report of the Market Dynamics and Commodities Ad-Hoc Committee to 23rd Board Meeting. [online]. Available at:
http://www.theglobalfund.org/documents/board/23/BM23_09MDC_
[Accessed 1 September 2016].
5. Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ: Br Med J. 335(7618):462.